-
1
-
-
0026492990
-
Anticardiolipin antibodies and the risk for ischemic stroke and venous thrombosis
-
Ginsburg KS, Liang MH, Newcomer L, Goldhaber SZ, Schur PH, Hennekens CH, Stampfer MJ. Anticardiolipin antibodies and the risk for ischemic stroke and venous thrombosis. Ann Intern Med. 1992;117: 997-1002.
-
(1992)
Ann Intern Med
, vol.117
, pp. 997-1002
-
-
Ginsburg, K.S.1
Liang, M.H.2
Newcomer, L.3
Goldhaber, S.Z.4
Schur, P.H.5
Hennekens, C.H.6
Stampfer, M.J.7
-
2
-
-
0036228886
-
-
Cervera R, Piette JC, Font J, Khamashta MA, Shoenfeld Y, Camps MT, Jacobsen S, Lakos G, Tincani A, Kontopoulou-Griva I, Galeazzi M, Meroni PL, Derksen RH, De Groot Gromnica-Ihle E, Baleva M, Mosca M, Bombardieri S, Houssiau F, Gris JC, Quere I, Hachulla E, Vasconcelos C, Roch B, Fernandez-Nebro A, Boffa MC, Hughes GR, Ingelmo M. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum. 2002;46:1019-1027.
-
Cervera R, Piette JC, Font J, Khamashta MA, Shoenfeld Y, Camps MT, Jacobsen S, Lakos G, Tincani A, Kontopoulou-Griva I, Galeazzi M, Meroni PL, Derksen RH, De Groot PG, Gromnica-Ihle E, Baleva M, Mosca M, Bombardieri S, Houssiau F, Gris JC, Quere I, Hachulla E, Vasconcelos C, Roch B, Fernandez-Nebro A, Boffa MC, Hughes GR, Ingelmo M. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum. 2002;46:1019-1027.
-
-
-
-
3
-
-
0033512274
-
International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: Report of an international workshop
-
Wilson WA, Gharavi AE, Koike T, Lockshin MD, Branch DW, Piette JC, Brey, Derksen R, Harris EN, Hughes GR, Triplett DA, Khamashta MA. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum. 1999;42:1309-1311.
-
(1999)
Arthritis Rheum
, vol.42
, pp. 1309-1311
-
-
Wilson, W.A.1
Gharavi, A.E.2
Koike, T.3
Lockshin, M.D.4
Branch, D.W.5
Piette, J.C.6
Brey7
Derksen, R.8
Harris, E.N.9
Hughes, G.R.10
Triplett, D.A.11
Khamashta, M.A.12
-
4
-
-
33344458573
-
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
-
Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, Derksen RH, De Groot PG, Koike T, Meroni PL, Reber G, Shoenfeld Y, Tincani A, Vlachoyiannopoulos PG, Krilis SA. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006;4:295-306.
-
(2006)
J Thromb Haemost
, vol.4
, pp. 295-306
-
-
Miyakis, S.1
Lockshin, M.D.2
Atsumi, T.3
Branch, D.W.4
Brey, R.L.5
Cervera, R.6
Derksen, R.H.7
De Groot, P.G.8
Koike, T.9
Meroni, P.L.10
Reber, G.11
Shoenfeld, Y.12
Tincani, A.13
Vlachoyiannopoulos, P.G.14
Krilis, S.A.15
-
5
-
-
0033887692
-
Antiphospholipid syndrome: Antibodies and antigens
-
Roubey RA. Antiphospholipid syndrome: antibodies and antigens. Curr Opin Hematol. 2000;7:316-320.
-
(2000)
Curr Opin Hematol
, vol.7
, pp. 316-320
-
-
Roubey, R.A.1
-
6
-
-
42949144324
-
Beta-2-glycoprotein 1-dependent macrophage uptake of apoptotic cells. Binding to lipoprotein receptor-related protein receptor family members
-
Maiti SN, Balasubramanian K, Ramoth JA, Schroit AJ. Beta-2-glycoprotein 1-dependent macrophage uptake of apoptotic cells. Binding to lipoprotein receptor-related protein receptor family members. J Biol Chem. 2008;283:3761-3766.
-
(2008)
J Biol Chem
, vol.283
, pp. 3761-3766
-
-
Maiti, S.N.1
Balasubramanian, K.2
Ramoth, J.A.3
Schroit, A.J.4
-
7
-
-
0034990570
-
A specific ligand for beta(2)-glycoprotein I mediates autoantibody-dependent uptake of oxidized low density lipoprotein by macrophages
-
Kobayashi K, Matsuura E, Liu Q, Furukawa J, Kaihara K, Inagaki J, Atsumi T, Sakairi N, Yasuda T, Voelker DR, Koike T. A specific ligand for beta(2)-glycoprotein I mediates autoantibody-dependent uptake of oxidized low density lipoprotein by macrophages. J Lipid Res. 2001;42: 697-709.
-
(2001)
J Lipid Res
, vol.42
, pp. 697-709
-
-
Kobayashi, K.1
Matsuura, E.2
Liu, Q.3
Furukawa, J.4
Kaihara, K.5
Inagaki, J.6
Atsumi, T.7
Sakairi, N.8
Yasuda, T.9
Voelker, D.R.10
Koike, T.11
-
8
-
-
1642399591
-
Beta 2-Glycoprotein I binds factor XI and inhibits its activation by thrombin and factor XIIa: Loss of inhibition by clipped beta 2-glycoprotein I
-
Shi T, Iverson GM, Qi JC, Cockerill KA, Linnik MD, Konecny P, Krilis SA. Beta 2-Glycoprotein I binds factor XI and inhibits its activation by thrombin and factor XIIa: loss of inhibition by clipped beta 2-glycoprotein I. Proc Natl Acad Sci U S A. 2004;101:3939-3944.
-
(2004)
Proc Natl Acad Sci U S A
, vol.101
, pp. 3939-3944
-
-
Shi, T.1
Iverson, G.M.2
Qi, J.C.3
Cockerill, K.A.4
Linnik, M.D.5
Konecny, P.6
Krilis, S.A.7
-
9
-
-
0033812286
-
2-glycoprotein I deficiency: Prevalence, genetic background and effects on plasma lipoprotein metabolism and hemostasis
-
2-glycoprotein I deficiency: prevalence, genetic background and effects on plasma lipoprotein metabolism and hemostasis. Atherosclerosis. 2000;152: 337-346.
-
(2000)
Atherosclerosis
, vol.152
, pp. 337-346
-
-
Yasuda, S.1
Tsutsumi, A.2
Chiba, H.3
Yanai, H.4
Miyoshi, Y.5
Takeuchi, R.6
Horita, T.7
Atsumi, T.8
Ichikawa, K.9
Matsuura, E.10
Koike, T.11
-
10
-
-
0030457493
-
Lupus anticoagulant in the strongest risk factor for both venous and arterial thrombosis in patients with systemic lupus erythematosus: Comparison between different assays for the detection of antiphospholipid antibodies
-
Horbach DA, Oort EV, Bonders RCJM, Derksen RHWM, De Groot PG. Lupus anticoagulant in the strongest risk factor for both venous and arterial thrombosis in patients with systemic lupus erythematosus: comparison between different assays for the detection of antiphospholipid antibodies. Thromb Haemost. 1996;76:916-924.
-
(1996)
Thromb Haemost
, vol.76
, pp. 916-924
-
-
Horbach, D.A.1
Oort, E.V.2
Bonders, R.C.J.M.3
Derksen, R.H.W.M.4
De Groot, P.G.5
-
11
-
-
0030779955
-
Risk for venous thrombosis related to antiphospholipid antibodies in systemic lupus erythematosus-a meta-analysis
-
Wahl DG, Guillemin F, de ME, Perret C, Lecompte T, Thibaut G. Risk for venous thrombosis related to antiphospholipid antibodies in systemic lupus erythematosus-a meta-analysis. Lupus. 1997;6:467-473.
-
(1997)
Lupus
, vol.6
, pp. 467-473
-
-
Wahl, D.G.1
Guillemin, F.2
de, M.E.3
Perret, C.4
Lecompte, T.5
Thibaut, G.6
-
12
-
-
32544444877
-
-
Cervera R, barca-Costalago M, Abramovicz D, Allegri F, Annunziata P, Aydintug AO, Bacarelli MR, Bellisai F, Bernardino I, Biernat-Kaluza E, Blockmans D, Boki K, Bracci L, Campanella V, Camps MT, Carcassi C, Cattaneo R, Cauli A, Cervera R, Chwalinska-Sadowska H, Contu L, Cosyns JP, Danieli MG, DCruz D, Depresseux G, Direskeneli H, Domenech I, Espinosa G, Fernandez-Nebro A, Ferrara GB, Font J, Frutos MA, Galeazzi M, Garcia-Carrasco M, Garcia Iglesias MF, Garcia-Tobaruela A, George J, Gil A, Gonzalez-Santos P, Grana M, Gul A, Haga HJ, de Haro-Liger M, Houssiau F, Hughes GR, Ingelmo M. Jedryka-Goral A, Khamashta MA, Lavilla P, Levi Y, Lopez-Dulpa M, Lopez-Soto A, Maldykowa H, Marcolongo R, Mathieu A, Morozzi G, Nicolopoulou N, Papasteriades C, Passiu G, Perello I, Petera P, Petrovic R, Piette JC, Pintado V, de PO, Popovic R, Pucci G, Puddu P, de RE, Ramos-Casals M, Rodriguez-Andreu J, Ruiz-Irastorza G, Sanchez-Lora J, Sanna G, Scorza R, Sebastiani GD, Sherer Y, Shoenfeld Y, Simpatico A, Si
-
Cervera R, barca-Costalago M, Abramovicz D, Allegri F, Annunziata P, Aydintug AO, Bacarelli MR, Bellisai F, Bernardino I, Biernat-Kaluza E, Blockmans D, Boki K, Bracci L, Campanella V, Camps MT, Carcassi C, Cattaneo R, Cauli A, Cervera R, Chwalinska-Sadowska H, Contu L, Cosyns JP, Danieli MG, DCruz D, Depresseux G, Direskeneli H, Domenech I, Espinosa G, Fernandez-Nebro A, Ferrara GB, Font J, Frutos MA, Galeazzi M, Garcia-Carrasco M, Garcia Iglesias MF, Garcia-Tobaruela A, George J, Gil A, Gonzalez-Santos P, Grana M, Gul A, Haga HJ, de Haro-Liger M, Houssiau F, Hughes GR, Ingelmo M. Jedryka-Goral A, Khamashta MA, Lavilla P, Levi Y, Lopez-Dulpa M, Lopez-Soto A, Maldykowa H, Marcolongo R, Mathieu A, Morozzi G, Nicolopoulou N, Papasteriades C, Passiu G, Perello I, Petera P, Petrovic R, Piette JC, Pintado V, de PO, Popovic R, Pucci G, Puddu P, de RE, Ramos-Casals M, Rodriguez-Andreu J, Ruiz-Irastorza G, Sanchez-Lora J, Sanna G, Scorza R, Sebastiani GD, Sherer Y, Shoenfeld Y, Simpatico A, Sinico RA, Smolen J, Tincani A, Tokgoz G, Urbano-Marquez A, Vasconcelos C, Vazquez JJ, Veronesi J, Vianna J, Vivancos J. Systemic lupus erythematosus in Europe at the change of the millennium: lessons from the "Euro-Lupus Project". Autoimmun Rev. 2006;5:180-186.
-
-
-
-
13
-
-
22244470734
-
Systemic lupus erythematosus in a multiethnic US cohort (LUMINA). XXV. Smoking, older age, disease activity, lupus anticoagulant, and glucocorticoid dose as risk factors for the occurrence of venous thrombosis in lupus patients
-
Calvo-Alen J, Toloza SM, Femandez M, Bastian HM, Fessier BJ, Roseman JM, McGwin G Jr, Vila LM, Reveille JD, Alarcon GS. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA). XXV. Smoking, older age, disease activity, lupus anticoagulant, and glucocorticoid dose as risk factors for the occurrence of venous thrombosis in lupus patients. Arthritis Rheum. 2005;52:2060-2068.
-
(2005)
Arthritis Rheum
, vol.52
, pp. 2060-2068
-
-
Calvo-Alen, J.1
Toloza, S.M.2
Femandez, M.3
Bastian, H.M.4
Fessier, B.J.5
Roseman, J.M.6
McGwin Jr, G.7
Vila, L.M.8
Reveille, J.D.9
Alarcon, G.S.10
-
14
-
-
0037370733
-
Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: A systematic review of the literature
-
Galli M, Luciani D, Bertolini G, Barbui T, Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature. Blood. 2003;101:1827-1832.
-
(2003)
Blood
, vol.101
, pp. 1827-1832
-
-
Galli, M.1
Luciani, D.2
Bertolini, G.3
Barbui, T.4
-
15
-
-
0031982693
-
Meta-analysis of the risk of venous thrombosis in individuals with antiphospholipid antibodies without underlying autoimmune disease or previous thrombosis
-
Wahl DG, Guillemin F, de ME, Perret-Guillaume C, Lecompte T, Thibaut G. Meta-analysis of the risk of venous thrombosis in individuals with antiphospholipid antibodies without underlying autoimmune disease or previous thrombosis. Lupus. 1998;7:15-22.
-
(1998)
Lupus
, vol.7
, pp. 15-22
-
-
Wahl, D.G.1
Guillemin, F.2
de, M.E.3
Perret-Guillaume, C.4
Lecompte, T.5
Thibaut, G.6
-
16
-
-
33644869517
-
A prospective study of anticardiolipin antibodies as a risk factor for venous thrombosis in a general population (the HUNT study)
-
Naess IA, Christiansen SC, Cannegieter SC, Rosendaal FR, Hammerstroem J. A prospective study of anticardiolipin antibodies as a risk factor for venous thrombosis in a general population (the HUNT study). J Thromb Haemost. 2006;4:44-49.
-
(2006)
J Thromb Haemost
, vol.4
, pp. 44-49
-
-
Naess, I.A.1
Christiansen, S.C.2
Cannegieter, S.C.3
Rosendaal, F.R.4
Hammerstroem, J.5
-
17
-
-
0036454495
-
Anticardiolipin antibodies as a risk factor for venous thromboembolism in a population-based prospective study
-
Runchey SS, Folsom AR, Tsai MY, Cushman M, McGovern PD. Anticardiolipin antibodies as a risk factor for venous thromboembolism in a population-based prospective study. Br J Haematol. 2002;119:1005-1010.
-
(2002)
Br J Haematol
, vol.119
, pp. 1005-1010
-
-
Runchey, S.S.1
Folsom, A.R.2
Tsai, M.Y.3
Cushman, M.4
McGovern, P.D.5
-
18
-
-
84941817790
-
Thrombosis, recurrent fetal loss, thrombocytopenia: Predictive value of IgG anticardiolipin antibodies
-
Harris EN, Chan JKH, Asherson RA, Aber VA, Gharavi AE, Hughes GRV. Thrombosis, recurrent fetal loss, thrombocytopenia: predictive value of IgG anticardiolipin antibodies. Arch Intern Med. 1986;146: 2153-2156.
-
(1986)
Arch Intern Med
, vol.146
, pp. 2153-2156
-
-
Harris, E.N.1
Chan, J.K.H.2
Asherson, R.A.3
Aber, V.A.4
Gharavi, A.E.5
Hughes, G.R.V.6
-
19
-
-
34347249882
-
Assessment of the 2006 revised antiphospholipid syndrome classification criteria
-
Kaul M, Erkan D, Sammaritano L, Lockshin MD. Assessment of the 2006 revised antiphospholipid syndrome classification criteria. Ann Rheum Dis. 2007;66:927-930.
-
(2007)
Ann Rheum Dis
, vol.66
, pp. 927-930
-
-
Kaul, M.1
Erkan, D.2
Sammaritano, L.3
Lockshin, M.D.4
-
20
-
-
3042787713
-
The contribution of inherited and acquired thrombophilic defects, alone or combined with antiphospholipid antibodies, to venous and arterial thromboembolism in patients with systemic lupus erythematosus
-
Brouwer JL, Bijl M, Veeger NJ, Kluin-Nelemans HC, van der MJ. The contribution of inherited and acquired thrombophilic defects, alone or combined with antiphospholipid antibodies, to venous and arterial thromboembolism in patients with systemic lupus erythematosus. Blood. 2004; 104:143-148.
-
(2004)
Blood
, vol.104
, pp. 143-148
-
-
Brouwer, J.L.1
Bijl, M.2
Veeger, N.J.3
Kluin-Nelemans, H.C.4
van der, M.J.5
-
21
-
-
0242693145
-
The presence of multiple prothrombotic risk factors is associated with a higher risk of thrombosis in individuals with anticardiolipin antibodies
-
Hudson M, Herr AL, Rauch J, Neville C, Chang E, Ibrahim R, Seguin C, Kassis J, Busque L, Fortin PR. The presence of multiple prothrombotic risk factors is associated with a higher risk of thrombosis in individuals with anticardiolipin antibodies. J Rheumatol. 2003;30:2385-2391.
-
(2003)
J Rheumatol
, vol.30
, pp. 2385-2391
-
-
Hudson, M.1
Herr, A.L.2
Rauch, J.3
Neville, C.4
Chang, E.5
Ibrahim, R.6
Seguin, C.7
Kassis, J.8
Busque, L.9
Fortin, P.R.10
-
22
-
-
0028173807
-
Effect of human IgG antiphospholipid antibodies on an in vivo thrombosis model in mice
-
Pierangeli SS, Barker JH, Stikovac D, Ackerman D, Anderson G, Barquinero J, Acland R, Harris EN. Effect of human IgG antiphospholipid antibodies on an in vivo thrombosis model in mice. Thromb Haemost. 1994;71:670-674.
-
(1994)
Thromb Haemost
, vol.71
, pp. 670-674
-
-
Pierangeli, S.S.1
Barker, J.H.2
Stikovac, D.3
Ackerman, D.4
Anderson, G.5
Barquinero, J.6
Acland, R.7
Harris, E.N.8
-
23
-
-
0028787634
-
Induction of thrombosis in a mouse model by IgG, IgM, and IgA immunoglobulins from patients with the antiphospholipid syndrome
-
Pierangeli SS, Liu XW, Barker JH, Anderson G, Harris EN. Induction of thrombosis in a mouse model by IgG, IgM, and IgA immunoglobulins from patients with the antiphospholipid syndrome. Thromb Haemost. 1995;74:1361-1367.
-
(1995)
Thromb Haemost
, vol.74
, pp. 1361-1367
-
-
Pierangeli, S.S.1
Liu, X.W.2
Barker, J.H.3
Anderson, G.4
Harris, E.N.5
-
25
-
-
0035793334
-
Thrombogenic effects of antiphospholipid antibodies are mediated by intercellular cell adhesion molecule-1, vascular cell adhesion molecule-1, and P-selectin
-
Pierangeli SS, Espinola RG, Liu X, Harris EN. Thrombogenic effects of antiphospholipid antibodies are mediated by intercellular cell adhesion molecule-1, vascular cell adhesion molecule-1, and P-selectin. Circ Res. 2001;88:245-250.
-
(2001)
Circ Res
, vol.88
, pp. 245-250
-
-
Pierangeli, S.S.1
Espinola, R.G.2
Liu, X.3
Harris, E.N.4
-
26
-
-
22244485396
-
Requirement of activation of complement C3 and C5 for antiphospholipid antibody-mediated thrombophilia
-
Pierangeli SS, Girardi G, Vega-Ostertag M, Liu X, Espinola RG, Salmon J. Requirement of activation of complement C3 and C5 for antiphospholipid antibody-mediated thrombophilia. Arthritis Rheum. 2005;52: 2120-2124.
-
(2005)
Arthritis Rheum
, vol.52
, pp. 2120-2124
-
-
Pierangeli, S.S.1
Girardi, G.2
Vega-Ostertag, M.3
Liu, X.4
Espinola, R.G.5
Salmon, J.6
-
27
-
-
34548079756
-
Role of p38 mitogen-activated protein kinase in antiphospholipid antibody-mediated thrombosis and endothelial cell activation
-
Vega-Ostertag ME, Ferrara DE, Romay-Penabad Z, Liu X, Taylor WR, Colden-Stanfield M, Pierangeli SS. Role of p38 mitogen-activated protein kinase in antiphospholipid antibody-mediated thrombosis and endothelial cell activation. J Thromb Haemost. 2007;5:1828-1834.
-
(2007)
J Thromb Haemost
, vol.5
, pp. 1828-1834
-
-
Vega-Ostertag, M.E.1
Ferrara, D.E.2
Romay-Penabad, Z.3
Liu, X.4
Taylor, W.R.5
Colden-Stanfield, M.6
Pierangeli, S.S.7
-
28
-
-
34948875756
-
In vivo effects of an inhibitor of nuclear factor-kappa B on thrombogenic properties of antiphospholipid antibodies
-
Montiel-Manzano G, Romay-Penabad Z, Papalardo de ME, Meillon-Garcia LA, Garcia-Latorre E, Reyes-Maldonado E, Pierangeli SS. In vivo effects of an inhibitor of nuclear factor-kappa B on thrombogenic properties of antiphospholipid antibodies. Ann NY Acad Sci. 2007;1108: 540-553.
-
(2007)
Ann NY Acad Sci
, vol.1108
, pp. 540-553
-
-
Montiel-Manzano, G.1
Romay-Penabad, Z.2
Papalardo de, M.E.3
Meillon-Garcia, L.A.4
Garcia-Latorre, E.5
Reyes-Maldonado, E.6
Pierangeli, S.S.7
-
29
-
-
0025001363
-
Inhibition of activated protein C and its cofactor protein S by antiphospholipid antibodies
-
Malia RG, Kitchen S, Greaves M, Preston FE. Inhibition of activated protein C and its cofactor protein S by antiphospholipid antibodies. Br J Haematol. 1990;76:101-107.
-
(1990)
Br J Haematol
, vol.76
, pp. 101-107
-
-
Malia, R.G.1
Kitchen, S.2
Greaves, M.3
Preston, F.E.4
-
30
-
-
0033404817
-
The putative mechanism of thrombosis in antiphospholipid syndrome: Impairment of the protein C and the fibrinolytic systems by monoclonal anticardiolipin antibodies
-
Ieko M, Sawada KI, Koike T, Notoya A, Mukai M, Kohno M, Wada N, Itoh T, Yoshioka N. The putative mechanism of thrombosis in antiphospholipid syndrome: impairment of the protein C and the fibrinolytic systems by monoclonal anticardiolipin antibodies. Semin Thromb Hemost. 1999;25:503-507.
-
(1999)
Semin Thromb Hemost
, vol.25
, pp. 503-507
-
-
Ieko, M.1
Sawada, K.I.2
Koike, T.3
Notoya, A.4
Mukai, M.5
Kohno, M.6
Wada, N.7
Itoh, T.8
Yoshioka, N.9
-
31
-
-
57149100983
-
Correlation between the potency of a beta2-glycoprotein I-dependent lupus anticoagulant and the level of resistance to activated protein C
-
de LB, Eckmann CM, van SM, Meijer AB, Mertens K, Van Mourik JA. Correlation between the potency of a beta2-glycoprotein I-dependent lupus anticoagulant and the level of resistance to activated protein C. Blood Coagul Fibrinolysis. 2008;19:757-764.
-
(2008)
Blood Coagul Fibrinolysis
, vol.19
, pp. 757-764
-
-
de, L.B.1
Eckmann, C.M.2
van, S.M.3
Meijer, A.B.4
Mertens, K.5
Van Mourik, J.A.6
-
32
-
-
59649088107
-
Tissue factor in the antiphospholipid syndrome
-
Kinev AV, Roubey RA. Tissue factor in the antiphospholipid syndrome. Lupus. 2008;17:952-958.
-
(2008)
Lupus
, vol.17
, pp. 952-958
-
-
Kinev, A.V.1
Roubey, R.A.2
-
33
-
-
34250158455
-
The tissue factor-factor Vila complex: Procoagulant activity, regulation, and multitasking
-
Monroe DM, Key NS. The tissue factor-factor Vila complex: procoagulant activity, regulation, and multitasking. J Thromb Haemost. 2007; 5:1097-1105.
-
(2007)
J Thromb Haemost
, vol.5
, pp. 1097-1105
-
-
Monroe, D.M.1
Key, N.S.2
-
34
-
-
3242697048
-
Characterization of monocyte tissue factor activity induced by IgG antiphospholipid antibodies and inhibition by dilazep
-
Zhou H, Wolberg AS, Roubey RAS. Characterization of monocyte tissue factor activity induced by IgG antiphospholipid antibodies and inhibition by dilazep. Blood. 2004;104:2353-2358.
-
(2004)
Blood
, vol.104
, pp. 2353-2358
-
-
Zhou, H.1
Wolberg, A.S.2
Roubey, R.A.S.3
-
35
-
-
0031886679
-
The role of the tissue factor pathway in the hypercoagulable state in patients with the antiphospholipid syndrome
-
Amengual O, Atsumi T, Khamashta MA, Hughes GRV. The role of the tissue factor pathway in the hypercoagulable state in patients with the antiphospholipid syndrome. Thromb Haemost. 1998;79:276-281.
-
(1998)
Thromb Haemost
, vol.79
, pp. 276-281
-
-
Amengual, O.1
Atsumi, T.2
Khamashta, M.A.3
Hughes, G.R.V.4
-
36
-
-
0031876263
-
Effects of human monoclonal anticardiolipin antibodies on platelet function and on tissue factor expression on monocytes
-
Reverter JC, Tassies D, Font J, Khamashta MA, Ichikawa K, Cervera R, Escolar G, Hughes GR, Ingelmo M, Ordinas A. Effects of human monoclonal anticardiolipin antibodies on platelet function and on tissue factor expression on monocytes. Arthritis Rheum. 1998;41:1420-1427.
-
(1998)
Arthritis Rheum
, vol.41
, pp. 1420-1427
-
-
Reverter, J.C.1
Tassies, D.2
Font, J.3
Khamashta, M.A.4
Ichikawa, K.5
Cervera, R.6
Escolar, G.7
Hughes, G.R.8
Ingelmo, M.9
Ordinas, A.10
-
37
-
-
18644361988
-
Involvement of p38 MAPK in the up-regulation of tissue factor on endothelial cells by antiphospholipid antibodies
-
Vega-Ostertag M, Casper K, Swerlick R, Ferrara D, Harris EN, Pierangeli SS. Involvement of p38 MAPK in the up-regulation of tissue factor on endothelial cells by antiphospholipid antibodies. Arthritis Rheum. 2005; 52:1545-1554.
-
(2005)
Arthritis Rheum
, vol.52
, pp. 1545-1554
-
-
Vega-Ostertag, M.1
Casper, K.2
Swerlick, R.3
Ferrara, D.4
Harris, E.N.5
Pierangeli, S.S.6
-
38
-
-
32344438085
-
Antiphospholipid-mediated thrombosis: Interplay between anticardiolipin antibodies and vascular cells
-
Lopez-Pedrera C, Buendia P, Barbarroja N, Siendones E, Velasco F, Cuadrado MJ. Antiphospholipid-mediated thrombosis: interplay between anticardiolipin antibodies and vascular cells. Clin Appl Thromb Hemost. 2006;12:41-45.
-
(2006)
Clin Appl Thromb Hemost
, vol.12
, pp. 41-45
-
-
Lopez-Pedrera, C.1
Buendia, P.2
Barbarroja, N.3
Siendones, E.4
Velasco, F.5
Cuadrado, M.J.6
-
39
-
-
1842413134
-
Thrombosis in primary antiphospholipid syndrome: A pivotal role for monocyte tissue factor expression
-
Cuadrado MJ, Lopez-Pedrera C, Khamashta MA, Camps MT, Tinahones F, Torres A, Hughes GRV, Velasco F. Thrombosis in primary antiphospholipid syndrome: a pivotal role for monocyte tissue factor expression. Arthritis Rheum. 1997;40:834-841.
-
(1997)
Arthritis Rheum
, vol.40
, pp. 834-841
-
-
Cuadrado, M.J.1
Lopez-Pedrera, C.2
Khamashta, M.A.3
Camps, M.T.4
Tinahones, F.5
Torres, A.6
Hughes, G.R.V.7
Velasco, F.8
-
40
-
-
0032700453
-
Increased levels of tissue factor mRNA in mononuclear blood cells of patients with primary antiphospholipid syndrome
-
Dobado-Berrios PM, Lopez-Pedrera C, Velasco F, Aguirre MA, Torres A, Cuadrado MJ. Increased levels of tissue factor mRNA in mononuclear blood cells of patients with primary antiphospholipid syndrome. Thromb Haemost. 1999;82:1578-1582.
-
(1999)
Thromb Haemost
, vol.82
, pp. 1578-1582
-
-
Dobado-Berrios, P.M.1
Lopez-Pedrera, C.2
Velasco, F.3
Aguirre, M.A.4
Torres, A.5
Cuadrado, M.J.6
-
41
-
-
0029911062
-
Hypercoagulable state in patients with antiphospholipid syndrome is related to high induced tissue factor expression on monocytes and to low free protein S
-
Reverter JC, Tassies D, Font J, Monteagudo J, Escolar G, Ingelmo M, Ordinas A. Hypercoagulable state in patients with antiphospholipid syndrome is related to high induced tissue factor expression on monocytes and to low free protein S. Arterioscler Thromb Vasc Biol. 1996;16:1319-1326.
-
(1996)
Arterioscler Thromb Vasc Biol
, vol.16
, pp. 1319-1326
-
-
Reverter, J.C.1
Tassies, D.2
Font, J.3
Monteagudo, J.4
Escolar, G.5
Ingelmo, M.6
Ordinas, A.7
-
42
-
-
36048993415
-
Tissue factor expression on monocytes induced by anti-phospholipid antibodies as a strong risk factor for thromboembolic complications in SLE patients
-
Nojima J, Masuda Y, Iwatani Y, Suehisa E, Futsukaichi Y, Kuratsune H, Watanabe Y, Takano T, Hidaka Y, Kanakura Y. Tissue factor expression on monocytes induced by anti-phospholipid antibodies as a strong risk factor for thromboembolic complications in SLE patients. Biochem Biophys Res Commun. 2008;365:195-200.
-
(2008)
Biochem Biophys Res Commun
, vol.365
, pp. 195-200
-
-
Nojima, J.1
Masuda, Y.2
Iwatani, Y.3
Suehisa, E.4
Futsukaichi, Y.5
Kuratsune, H.6
Watanabe, Y.7
Takano, T.8
Hidaka, Y.9
Kanakura, Y.10
-
43
-
-
33749118495
-
A novel C5a receptor-tissue factor cross-talk in neutrophils links innate immunity to coagulation pathways
-
Ritis K, Doumas M, Mastellos D, Micheli A, Giaglis S, Magotti P, Rafail S, Kartalis G, Sideras P, Lambris JD. A novel C5a receptor-tissue factor cross-talk in neutrophils links innate immunity to coagulation pathways. J Immunol. 2006;177:4794-4802.
-
(2006)
J Immunol
, vol.177
, pp. 4794-4802
-
-
Ritis, K.1
Doumas, M.2
Mastellos, D.3
Micheli, A.4
Giaglis, S.5
Magotti, P.6
Rafail, S.7
Kartalis, G.8
Sideras, P.9
Lambris, J.D.10
-
44
-
-
0028908094
-
The management of thrombosis in the antiphospholipid-antibody syndrome
-
Khamashta MA, Cuadrado MJ, Mujic F, Taub NA, Hunt BJ, Hughes GRV. The management of thrombosis in the antiphospholipid-antibody syndrome. N Engl J Med. 1995;332:993-997.
-
(1995)
N Engl J Med
, vol.332
, pp. 993-997
-
-
Khamashta, M.A.1
Cuadrado, M.J.2
Mujic, F.3
Taub, N.A.4
Hunt, B.J.5
Hughes, G.R.V.6
-
45
-
-
0141791073
-
A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome
-
Crowther MA, Ginsberg JS, Julian J, Denburg J, Hirsh J, Douketis J, Laskin C, Fortin P, Anderson D, Kearon C, Clarke A, Geerts W, Forgie M, Green D, Costantini L, Yacura W, Wilson S, Gent M, Kovacs MJ. A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome. N Engl J Med. 2003;349:1133-1138.
-
(2003)
N Engl J Med
, vol.349
, pp. 1133-1138
-
-
Crowther, M.A.1
Ginsberg, J.S.2
Julian, J.3
Denburg, J.4
Hirsh, J.5
Douketis, J.6
Laskin, C.7
Fortin, P.8
Anderson, D.9
Kearon, C.10
Clarke, A.11
Geerts, W.12
Forgie, M.13
Green, D.14
Costantini, L.15
Yacura, W.16
Wilson, S.17
Gent, M.18
Kovacs, M.J.19
-
46
-
-
23844437705
-
A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS)
-
Finazzi G, Marchioli R, Brancaccio V, Schinco P, Wisloff F, Musial J, Baudo F, Berrettini M, Testa S, D'Angelo A, Tognoni G, Barbui T. A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS). J Thromb Haemost. 2005; 3:848-853.
-
(2005)
J Thromb Haemost
, vol.3
, pp. 848-853
-
-
Finazzi, G.1
Marchioli, R.2
Brancaccio, V.3
Schinco, P.4
Wisloff, F.5
Musial, J.6
Baudo, F.7
Berrettini, M.8
Testa, S.9
D'Angelo, A.10
Tognoni, G.11
Barbui, T.12
-
47
-
-
37349061734
-
A systematic review of secondary thromboprophylaxis in patients with antiphospholipid antibodies
-
Ruiz-Irastorza G, Hunt BJ, Khamashta MA. A systematic review of secondary thromboprophylaxis in patients with antiphospholipid antibodies. Arthritis Care Res. 2007;57:1487-1495.
-
(2007)
Arthritis Care Res
, vol.57
, pp. 1487-1495
-
-
Ruiz-Irastorza, G.1
Hunt, B.J.2
Khamashta, M.A.3
-
48
-
-
0031203621
-
Monitoring warfarin therapy in patients with lupus anticoagulants
-
Moll S, Ortel TL. Monitoring warfarin therapy in patients with lupus anticoagulants. Ann Intern Med. 1997;127:177-185.
-
(1997)
Ann Intern Med
, vol.127
, pp. 177-185
-
-
Moll, S.1
Ortel, T.L.2
-
49
-
-
6744257508
-
Falsely elevated INRs in warfarin-treated patients with the lupus anticoagulant
-
Sanfelippo MJ, Sennet J, McMahon EJ. Falsely elevated INRs in warfarin-treated patients with the lupus anticoagulant. WMJ. 2000;99: 62-64.
-
(2000)
WMJ
, vol.99
, pp. 62-64
-
-
Sanfelippo, M.J.1
Sennet, J.2
McMahon, E.J.3
-
50
-
-
3042701142
-
Unreliability of international normalized ratio for monitoring warfarin therapy in patients with lupus anticoagulant
-
Rosborough TK, Shepherd MF. Unreliability of international normalized ratio for monitoring warfarin therapy in patients with lupus anticoagulant. Pharmacotherapy. 2004;24:838-842.
-
(2004)
Pharmacotherapy
, vol.24
, pp. 838-842
-
-
Rosborough, T.K.1
Shepherd, M.F.2
-
51
-
-
37349096325
-
Warfarin and the antiphospholipid syndrome: Does one size fit all?
-
Kasthuri RS, Roubey RA. Warfarin and the antiphospholipid syndrome: does one size fit all? Arthritis Rheum. 2007;57:1346-1347.
-
(2007)
Arthritis Rheum
, vol.57
, pp. 1346-1347
-
-
Kasthuri, R.S.1
Roubey, R.A.2
-
52
-
-
0038053217
-
Antiphospholipid antibodies and thrombosis: Strength of association
-
Galli M, Barbui T. Antiphospholipid antibodies and thrombosis: strength of association. Hematol J. 2003;4:180-186.
-
(2003)
Hematol J
, vol.4
, pp. 180-186
-
-
Galli, M.1
Barbui, T.2
-
53
-
-
0027203896
-
Patients with antiphospholipid antibodies and venous thrombosis should receive long term anticoagulant treatment
-
Derksen RHWM, De Groot PG, Kater L, Nieuwenhuis HK. Patients with antiphospholipid antibodies and venous thrombosis should receive long term anticoagulant treatment. Ann Rheum Dis. 1993;52:689-692.
-
(1993)
Ann Rheum Dis
, vol.52
, pp. 689-692
-
-
Derksen, R.H.W.M.1
De Groot, P.G.2
Kater, L.3
Nieuwenhuis, H.K.4
-
54
-
-
32144435725
-
Rituximab treatment for resistant antiphospholipid syndrome
-
Rubenstein E, Arkfeld DG, Metyas S, Shinada S, Ehresmann S, Liebman HA. Rituximab treatment for resistant antiphospholipid syndrome. J Rheumatol. 2006;33:355-357.
-
(2006)
J Rheumatol
, vol.33
, pp. 355-357
-
-
Rubenstein, E.1
Arkfeld, D.G.2
Metyas, S.3
Shinada, S.4
Ehresmann, S.5
Liebman, H.A.6
-
55
-
-
38049059906
-
Rituximab effectively reverses papilledema associated with cerebral venous sinus thrombosis in antiphospholipid antibody syndrome
-
Chalam KV, Gupta SK, Agarwal S. Rituximab effectively reverses papilledema associated with cerebral venous sinus thrombosis in antiphospholipid antibody syndrome. Eur J Ophthalmol. 2007;17:867-870.
-
(2007)
Eur J Ophthalmol
, vol.17
, pp. 867-870
-
-
Chalam, K.V.1
Gupta, S.K.2
Agarwal, S.3
-
56
-
-
61949133655
-
Clinical improvement in antiphospholipid syndrome after rituximab therapy
-
Adamson R, Sangle S, Kaul A, Hughes GR, D'Cruz DP. Clinical improvement in antiphospholipid syndrome after rituximab therapy. J Clin Rheumatol. 2008;14:359-360.
-
(2008)
J Clin Rheumatol
, vol.14
, pp. 359-360
-
-
Adamson, R.1
Sangle, S.2
Kaul, A.3
Hughes, G.R.4
D'Cruz, D.P.5
-
57
-
-
34547407889
-
Aspirin for primary thrombosis prevention in the antiphospholipid syndrome: A randomized, double-blind, placebo-controlled trial in asymptomatic antiphospholipid antibody-positive individuals
-
Erkan D, Harrison MJ, Levy R, Peterson M, Petri M, Sammaritano L, Unalp-Arida A, Vilela V, Yazici Y, Lockshin MD. Aspirin for primary thrombosis prevention in the antiphospholipid syndrome: a randomized, double-blind, placebo-controlled trial in asymptomatic antiphospholipid antibody-positive individuals. Arthritis Rheum. 2007;56:2382-2391.
-
(2007)
Arthritis Rheum
, vol.56
, pp. 2382-2391
-
-
Erkan, D.1
Harrison, M.J.2
Levy, R.3
Peterson, M.4
Petri, M.5
Sammaritano, L.6
Unalp-Arida, A.7
Vilela, V.8
Yazici, Y.9
Lockshin, M.D.10
-
58
-
-
0029990745
-
Hydroxychloroquine use in the Baltimore Lupus Cohort: Effects on lipids, glucose and thrombosis
-
Petri M. Hydroxychloroquine use in the Baltimore Lupus Cohort: effects on lipids, glucose and thrombosis. Lupus. 1996;5:S16-S22.
-
(1996)
Lupus
, vol.5
-
-
Petri, M.1
-
59
-
-
33750499270
-
Effect of antimalarials on thrombosis and survival in patients with systemic lupus erythematosus
-
Ruiz-Irastorza G, Egurbide MV, Pijoan JI, Garmendia M, Villar I, Martinez-Berriotxoa A, Erdozain JG, Aguirre C. Effect of antimalarials on thrombosis and survival in patients with systemic lupus erythematosus. Lupus. 2006;15:577-583.
-
(2006)
Lupus
, vol.15
, pp. 577-583
-
-
Ruiz-Irastorza, G.1
Egurbide, M.V.2
Pijoan, J.I.3
Garmendia, M.4
Villar, I.5
Martinez-Berriotxoa, A.6
Erdozain, J.G.7
Aguirre, C.8
|